SCOTT RANDAL W. sold 46.3% of their position (10K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $754.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/18/2026ACC: 0001470831-26-000182
-10K
Net shares
Net seller
$754.6K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+10K
Price / share
$16.75
Trade value
$167.50K
% of position
86.3%
2/17/2026
11.59K→21.59K
Common Stock
Direct
Shares
−1.90K
Price / share
$74.34
Trade value
$141.25K
% of position
8.8%
2/17/2026
21.59K→19.69K
Common Stock
Direct
Shares
−4.79K
Price / share
$75.57
Trade value
$362.22K
% of position
24.3%
2/17/2026
19.69K→14.90K
Common Stock
Direct
Shares
−3.31K
Price / share
$75.93
Trade value
$251.09K
% of position
22.2%
2/17/2026
14.90K→11.59K
Total
Net shares
+0.00
Net value
-$587.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | M · Option Exercise | +10K | $16.75 | $167.50K | 86.3% | 11.59K | 21.59K |
| Common Stock Direct | 2/17/2026 | S · Sale | −1.90K | $74.34 | $141.25K | 8.8% | 21.59K | 19.69K |
| Common Stock Direct | 2/17/2026 | S · Sale | −4.79K | $75.57 | $362.22K | 24.3% | 19.69K | 14.90K |
| Common Stock Direct | 2/17/2026 | S · Sale | −3.31K | $75.93 | $251.09K | 22.2% | 14.90K | 11.59K |
| Total | +0.00 | -$587.06K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
16.75
Held after
31.50K
Exercisable
—
2/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10K shares | 2/17/2026 | M · Option Exercise | −10K | 16.75 | — | 31.50K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4K
Total
4K indirect4K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4K | Indirect |
| Total | 4K | 4K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported